Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 32 most recent Form 4 transactions.
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 4,000 | $92.01 | $368.1K | -1.7% | Open the original filing on SEC.gov |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 1,000 | $91.05 | $91K | -0.4% | Open the original filing on SEC.gov |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 5,000 | $7.80 | $39K | +2.1% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 500 | $95.47 | $47.7K | -0.2% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,263 | $94.75 | $214.4K | -0.9% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,237 | $93.85 | $209.9K | -0.9% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 5,000 | $7.80 | $39K | +2.1% | Open the original filing on SEC.gov |
| Jun 15 | ORKA | Oruka Therapeutics, Inc. | SSELL | 600 | $69.69 | $41.8K | -0.3% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 100 | $68.48 | $6.8K | <0.1% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 200 | $67.16 | $13.4K | <0.1% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 400 | $66.06 | $26.4K | -0.2% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 300 | $65.10 | $19.5K | -0.1% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 1,800 | $64.15 | $115.5K | -0.8% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,200 | $62.58 | $137.7K | -0.9% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 5,000 | $7.80 | $39K | +2.1% | Open the original filing on SEC.gov |
| Mar 16 | ORKA | Oruka Therapeutics, Inc. | SSELL | 600 | $41.30 | $24.8K | -0.3% | Open the original filing on SEC.gov |
| Mar 2 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,675 | $33.81 | $90.4K | -1.1% | Open the original filing on SEC.gov |
| Mar 2 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,325 | $33.28 | $77.4K | -1.0% | Open the original filing on SEC.gov |
| Mar 2 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 5,000 | $7.80 | $39K | +2.1% | Open the original filing on SEC.gov |
| Jan 23 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 130,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 23 | ORKA | Oruka Therapeutics, Inc. | AGRANT | 32,500 | — | — | +15.8% | Open the original filing on SEC.gov |
| Jan 2 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 1,108 | $29.75 | $33K | -0.5% | Open the original filing on SEC.gov |
| Jan 2 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 3,144 | $29.08 | $91.4K | -1.5% | Open the original filing on SEC.gov |
| Jan 2 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 8,748 | $28.17 | $246.4K | -4.0% | Open the original filing on SEC.gov |
| Jan 2 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 5,000 | $7.80 | $39K | +2.4% | Open the original filing on SEC.gov |
| Jul 1, 2025 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |